CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.

Current opinion in investigational drugs (London …, 2003 - europepmc.org
Synthetic oligodeoxynucleotides containing CG motifs (CpG ODNs) have potent
immunostimulatory properties, and have potential as immunotherapeutic agents in cancer …

CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy

B Jahrsdörfer, GJ Weiner - Current opinion in …, 2003 - pubmed.ncbi.nlm.nih.gov
Synthetic oligodeoxynucleotides containing CG motifs (CpG ODNs) have potent
immunostimulatory properties, and have potential as immunotherapeutic agents in cancer …

CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy

B Jahrsdörfer, GJ Weiner - Current opinion in investigational drugs …, 2003 - iro.uiowa.edu
Synthetic oligodeoxynucleotides containing CG motifs (CpG ODNs) have potent
immunostimulatory properties, and have potential as immunotherapeutic agents in cancer …

[引用][C] CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy

B JAHRSDORFER - Curr Opin Investig Drugs, 2003 - cir.nii.ac.jp
CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[引用][C] CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy

B JAHRSDORFER - Curr. Opin. Invest. Drugs, 2003 - cir.nii.ac.jp